264 related articles for article (PubMed ID: 33360047)
1. Evaluation of the gut microbiota after metformin intervention in children with obesity: A metagenomic study of a randomized controlled trial.
Pastor-Villaescusa B; Plaza-Díaz J; Egea-Zorrilla A; Leis R; Bueno G; Hoyos R; Vázquez-Cobela R; Latorre M; Cañete MD; Caballero-Villarraso J; Gil Á; Cañete R; Aguilera CM
Biomed Pharmacother; 2021 Feb; 134():111117. PubMed ID: 33360047
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of differential effects of metformin treatment in obese children according to pubertal stage and genetic variations: study protocol for a randomized controlled trial.
Pastor-Villaescusa B; Caballero-Villarraso J; Cañete MD; Hoyos R; Maldonado J; Bueno G; Leis R; Gil Á; Cañete R; Aguilera CM
Trials; 2016 Jul; 17(1):323. PubMed ID: 27432166
[TBL] [Abstract][Full Text] [Related]
3. Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up.
Wilson DM; Abrams SH; Aye T; Lee PD; Lenders C; Lustig RH; Osganian SV; Feldman HA;
Arch Pediatr Adolesc Med; 2010 Feb; 164(2):116-23. PubMed ID: 20124139
[TBL] [Abstract][Full Text] [Related]
4. Drug interventions for the treatment of obesity in children and adolescents.
Mead E; Atkinson G; Richter B; Metzendorf MI; Baur L; Finer N; Corpeleijn E; O'Malley C; Ells LJ
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012436. PubMed ID: 27899001
[TBL] [Abstract][Full Text] [Related]
5. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study.
Bryrup T; Thomsen CW; Kern T; Allin KH; Brandslund I; Jørgensen NR; Vestergaard H; Hansen T; Hansen TH; Pedersen O; Nielsen T
Diabetologia; 2019 Jun; 62(6):1024-1035. PubMed ID: 30904939
[TBL] [Abstract][Full Text] [Related]
6. Metformin for Obesity in Prepubertal and Pubertal Children: A Randomized Controlled Trial.
Pastor-Villaescusa B; Cañete MD; Caballero-Villarraso J; Hoyos R; Latorre M; Vázquez-Cobela R; Plaza-Díaz J; Maldonado J; Bueno G; Leis R; Gil Á; Cañete R; Aguilera CM
Pediatrics; 2017 Jul; 140(1):. PubMed ID: 28759403
[TBL] [Abstract][Full Text] [Related]
7. Probiotic supplementation increases obesity with no detectable effects on liver fat or gut microbiota in obese Hispanic adolescents: a 16-week, randomized, placebo-controlled trial.
Jones RB; Alderete TL; Martin AA; Geary BA; Hwang DH; Palmer SL; Goran MI
Pediatr Obes; 2018 Nov; 13(11):705-714. PubMed ID: 29493105
[TBL] [Abstract][Full Text] [Related]
8. Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats.
Zhang M; Feng R; Yang M; Qian C; Wang Z; Liu W; Ma J
BMJ Open Diabetes Res Care; 2019; 7(1):e000717. PubMed ID: 31641523
[TBL] [Abstract][Full Text] [Related]
9. Effects of metformin on energy intake and satiety in obese children.
Adeyemo MA; McDuffie JR; Kozlosky M; Krakoff J; Calis KA; Brady SM; Yanovski JA
Diabetes Obes Metab; 2015 Apr; 17(4):363-70. PubMed ID: 25483291
[TBL] [Abstract][Full Text] [Related]
10. Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial.
Wei S; Mortensen MS; Stokholm J; Brejnrod AD; Thorsen J; Rasmussen MA; Trivedi U; Bisgaard H; Sørensen SJ
EBioMedicine; 2018 Dec; 38():265-272. PubMed ID: 30478001
[TBL] [Abstract][Full Text] [Related]
11. Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity.
Nicolucci AC; Hume MP; Martínez I; Mayengbam S; Walter J; Reimer RA
Gastroenterology; 2017 Sep; 153(3):711-722. PubMed ID: 28596023
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.
van der Aa MP; Elst MA; van de Garde EM; van Mil EG; Knibbe CA; van der Vorst MM
Nutr Diabetes; 2016 Aug; 6(8):e228. PubMed ID: 27571249
[TBL] [Abstract][Full Text] [Related]
13. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
14. Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial.
Dodd JM; Louise J; Deussen AR; Grivell RM; Dekker G; McPhee AJ; Hague W
Lancet Diabetes Endocrinol; 2019 Jan; 7(1):15-24. PubMed ID: 30528218
[TBL] [Abstract][Full Text] [Related]
15. 16S rRNA Sequencing and Metagenomics Study of Gut Microbiota: Implications of BDB on Type 2 Diabetes Mellitus.
Zhang L; Luo J; Li X; Guo S; Shi D
Mar Drugs; 2020 Sep; 18(9):. PubMed ID: 32957565
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Metformin for Obesity: A Systematic Review.
Masarwa R; Brunetti VC; Aloe S; Henderson M; Platt RW; Filion KB
Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33608415
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota of Chinese Obese Children and Adolescents With and Without Insulin Resistance.
Yuan X; Chen R; Zhang Y; Lin X; Yang X; McCormick KL
Front Endocrinol (Lausanne); 2021; 12():636272. PubMed ID: 33815293
[TBL] [Abstract][Full Text] [Related]
18. Metformin in the Management of Childhood Obesity: A Randomized Control Trial.
Warnakulasuriya LS; Fernando MMA; Adikaram AVN; Thawfeek ARM; Anurasiri WL; Silva RR; Sirasa MSF; Rytter E; Forslund AH; Samaranayake DL; Wickramasinghe VP
Child Obes; 2018; 14(8):553-565. PubMed ID: 30070925
[TBL] [Abstract][Full Text] [Related]
19. Metagenomics analysis of gut microbiota in response to diet intervention and gestational diabetes in overweight and obese women: a randomised, double-blind, placebo-controlled clinical trial.
Mokkala K; Paulin N; Houttu N; Koivuniemi E; Pellonperä O; Khan S; Pietilä S; Tertti K; Elo LL; Laitinen K
Gut; 2021 Feb; 70(2):309-318. PubMed ID: 32839200
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of metformin and fermentable fiber combination therapy in adolescents with severe obesity and insulin resistance: study protocol for a double-blind randomized controlled trial.
Deehan EC; Colin-Ramirez E; Triador L; Madsen KL; Prado CM; Field CJ; Ball GDC; Tan Q; Orsso C; Dinu I; Pakseresht M; Rubin D; Sharma AM; Tun H; Walter J; Newgard CB; Freemark M; Wine E; Haqq AM
Trials; 2021 Feb; 22(1):148. PubMed ID: 33596993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
